TMC Still Optimistic About Cangrelor Approval Despite Negative Opinion
This article was originally published in The Pink Sheet Daily
Executive Summary
The Medicines Company seemed positive about the prospects for approval of its anti-clotting drug, even though an advisory committee voted against approval just a week ago.